Literature DB >> 31504537

The Changing Epidemiology of Inflammatory Bowel Disease: What Goes Up May Come Down.

Hamed Khalili1,2.   

Abstract

Recent epidemiologic studies have shown that although the incidence of inflammatory bowel disease (IBD) is rapidly increasing in newly industrialized countries, at the turn of the 21st century the incidence had stabilized in the Western world. In this issue of Inflammatory Bowel Diseases, Torabi and colleagues present their findings on the temporal trends and geographic variations in IBD incidence in Manitoba from 1990 to 2012 using the Manitoba Health population registry and the University of Manitoba IBD epidemiology database. Their results demonstrate an overall decrease in the incidence of IBD during the study period. They also found significant regional variations in disease incidence within Manitoba, with rates of new diagnosis of IBD remaining high in several regions. Lastly, the study found that a higher proportion of the indigenous population had a lower rate of IBD. These findings provide new insights on the changing epidemiology of IBD in the Western world. The overall declining incidence of IBD and identification of persistently low and high-risk populations in Manitoba, which traditionally has had some of the highest incidence rates of IBD, is intriguing and can provide new avenues of research for epidemiologists in the field.
© 2019 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; epidemiology; inflammatory bowel disease; time trend; ulcerative colitis

Mesh:

Year:  2020        PMID: 31504537      PMCID: PMC7056818          DOI: 10.1093/ibd/izz186

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  3 in total

Review 1.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.

Authors:  Siew C Ng; Hai Yun Shi; Nima Hamidi; Fox E Underwood; Whitney Tang; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung; Gilaad G Kaplan
Journal:  Lancet       Date:  2017-10-16       Impact factor: 79.321

2.  Geographical Variation and Factors Associated With Inflammatory Bowel Disease in a Central Canadian Province.

Authors:  Mahmoud Torabi; Charles N Bernstein; B Nancy Yu; Lahiru Wickramasinghe; James F Blanchard; Harminder Singh
Journal:  Inflamm Bowel Dis       Date:  2020-03-04       Impact factor: 5.325

3.  Decreasing incidence of inflammatory bowel disease in eastern Canada: a population database study.

Authors:  Desmond Leddin; Hala Tamim; Adrian R Levy
Journal:  BMC Gastroenterol       Date:  2014-08-09       Impact factor: 3.067

  3 in total
  4 in total

1.  α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study.

Authors:  Balaji Venkataraman; Saeeda Almarzooqi; Vishnu Raj; Pradeep K Dudeja; Bhoomendra A Bhongade; Rajesh B Patil; Shreesh K Ojha; Samir Attoub; Thomas E Adrian; Sandeep B Subramanya
Journal:  PPAR Res       Date:  2022-04-13       Impact factor: 4.385

2.  TLR4 promoted endoplasmic reticulum stress induced inflammatory bowel disease via the activation of p38 MAPK pathway.

Authors:  Tian Hu; Yan Zhao; Yan Long; Xiaoqing Ma; Ya Zeng; Weijie Wu; Chongtian Deng; Mengling Li; Siyuan Peng; Hanzhi Yang; Mi Zhou; Jinyue Hu; Yueming Shen
Journal:  Biosci Rep       Date:  2022-04-29       Impact factor: 3.976

3.  Incidence Trends of Inflammatory Bowel Disease in a Southern European Country: A Mirror of the Western World?

Authors:  Mafalda Santiago; Francisco Stocker; Paula Ministro; Raquel Gonçalves; Diana Carvalho; Francisco Portela; Luís Correia; Paula Lago; Eunice Trindade; Cláudia Camila Dias; Fernando Magro
Journal:  Clin Transl Gastroenterol       Date:  2022-05-01       Impact factor: 4.396

4.  A proteomic and RNA-seq transcriptomic dataset of capsaicin-aggravated mouse chronic colitis model.

Authors:  Kexin Chen; Silan Shen; Yiding Chen; Mingshan Jiang; Kehan Hu; Yuheng Zou; Lili Li; Zhen Zeng; Chunxiang Ma; Yuan Dang; Hu Zhang
Journal:  Sci Data       Date:  2022-09-07       Impact factor: 8.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.